Largest health care companies — Page 5
The 1,019 US-listed companies in the health care sector, ranked by market capitalisation. Sector comes from each company's Nasdaq classification; revenue and earnings come from its SEC filings.
Combined market cap
$9.815 T
10.5% of all US-listed value
Companies
1,019
Ranked #4 of 12 sectors
Average
$9.632 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 401 | Myriad GeneticsMYGN | $597.3M | $6.25 | +3.74% | United States |
| 402 | Immix BiopharmaIMMX | $597.3M | $7.21 | -9.60% | United States |
| 403 | Olema PharmaceuticalsOLMA | $593.7M | $6.79 | -10.01% | United States |
| 404 | Tactile Systems TechnologyTCMD | $591.5M | $26.41 | -2.85% | United States |
| 405 | ApnimedAPMD | $589.1M | $14.15 | -7.52% | United States |
| 406 | Arbutus BiopharmaABUS | $561.8M | $3.67 | -9.73% | Canada |
| 407 | Iambic TherapeuticsIAM | $550.1M | $11.61 | -13.40% | United States |
| 408 | Bicara TherapeuticsBCAX | $542.6M | $8.20 | -7.76% | United States |
| 409 | Anteris Technologies GlobalAVR | $542.6M | $5.57 | -9.07% | United States |
| 410 | Nrc HealthNRC | $538.5M | $25.38 | -6.26% | United States |
| 411 | Sight SciencesSGHT | $537.3M | $9.67 | -0.12% | United States |
| 412 | Valneva SEVALN | $532.9M | $5.62 | -0.24% | France |
| 413 | Aclaris TherapeuticsACRS | $529.9M | $3.60 | -2.17% | United States |
| 414 | Anbio BiotechnologyNNNN | $529.5M | $3.68 | +0.00% | Germany |
| 415 | Entera BioENTX | $521.8M | $3.00 | -3.54% | Israel |
| 416 | SurrozenSRZN | $517.4M | $29.07 | -8.15% | United States |
| 417 | SBC Medical GroupSBC | $516.3M | $5.02 | -5.64% | United States |
| 418 | NeurogeneNGNE | $516.1M | $25.79 | -6.49% | Canada |
| 419 | YD BioYDES | $511.4M | $7.22 | +3.88% | United States |
| 420 | Fulgent GeneticsFLGT | $511.0M | $18.57 | -5.64% | United States |
| 421 | Climb BioCLYM | $510.0M | $8.88 | -4.82% | United States |
| 422 | Faeth TherapeuticsFTH | $509.9M | $19.73 | -1.30% | United States |
| 423 | Puma BiotechnologyPBYI | $505.4M | $9.79 | -8.42% | United States |
| 424 | SL ScienceSLBT | $504.7M | $0.90 | -18.92% | Taiwan |
| 425 | Ovid TherapeuticsOVID | $503.9M | $2.58 | -5.84% | United States |
| 426 | Delcath SystemsDCTH | $503.8M | $14.52 | -2.02% | United States |
| 427 | Capricor TherapeuticsCAPR | $499.4M | $8.59 | -3.70% | United States |
| 428 | AngiodynamicsANGO | $496.2M | $11.80 | -3.67% | United States |
| 429 | Jin Medical InternationalZJYL | $493.6M | $3.12 | +0.97% | China |
| 430 | AVITA MedicalRCEL | $489.8M | $15.64 | -4.17% | United States |
| 431 | DiaMedica TherapeuticsDMAC | $488.6M | $9.06 | -15.88% | United States |
| 432 | RegenxbioRGNX | $487.2M | $7.38 | -4.28% | United States |
| 433 | Alpha TeknovaTKNO | $484.9M | $7.86 | +6.63% | United States |
| 434 | Indaptus TherapeuticsINDP | $483.8M | $3.15 | -4.54% | United States |
| 435 | Crescent BiopharmaCBIO | $482.1M | $12.98 | -6.08% | United States |
| 436 | Mimedx GroupMDXG | $476.4M | $3.27 | +2.03% | United States |
| 437 | Strata Critical MedicalSRTA | $469.4M | $5.26 | +0.67% | United States |
| 438 | CytomX TherapeuticsCTMX | $467.4M | $2.15 | -8.72% | United States |
| 439 | Aquestive TherapeuticsAQST | $458.1M | $3.65 | -4.08% | United States |
| 440 | EvolusEOLS | $452.4M | $6.84 | -8.50% | United States |
| 441 | Monopar TherapeuticsMNPR | $450.8M | $67.16 | -7.76% | United States |
| 442 | Shattuck LabsSTTK | $450.1M | $4.49 | -12.91% | United States |
| 443 | Electra TherapeuticsETRA | $449.4M | $7.16 | -10.16% | United States |
| 444 | Gyre TherapeuticsGYRE | $446.6M | $4.01 | -9.80% | United States |
| 445 | Eupraxia PharmaceuticalsEPRX | $436.6M | $6.63 | -2.00% | Canada |
| 446 | NeuroPaceNPCE | $434.5M | $12.66 | -5.10% | United States |
| 447 | CerusCERS | $429.8M | $2.13 | -11.88% | United States |
| 448 | ArvinasARVN | $427.0M | $6.52 | -12.13% | United States |
| 449 | Shoulder InnovationsSI | $426.8M | $20.50 | -2.43% | United States |
| 450 | BrainswayBWAY | $426.8M | $10.64 | -5.13% | Israel |
| 451 | SenseonicsSENS | $422.2M | $7.99 | -11.47% | United States |
| 452 | OculisOCS | $419.1M | $6.81 | -6.53% | Switzerland |
| 453 | CarlsmedCARL | $416.4M | $15.25 | -5.22% | United States |
| 454 | Tilray BrandsTLRY | $416.0M | $2.82 | -4.90% | United States |
| 455 | Phathom PharmaceuticalsPHAT | $413.0M | $5.08 | -10.56% | United States |
| 456 | CorMedixCRMD | $407.3M | $5.23 | -7.69% | United States |
| 457 | Prothena Corp PublicPRTA | $406.3M | $7.92 | -5.66% | United States |
| 458 | Relmada TherapeuticsRLMD | $402.7M | $3.78 | -9.47% | United States |
| 459 | MapLight TherapeuticsMPLT | $402.2M | $6.21 | -7.45% | United States |
| 460 | Assembly BiosciencesASMB | $401.7M | $19.73 | -0.70% | United States |
| 461 | KamadaKMDA | $397.0M | $6.88 | -7.28% | Israel |
| 462 | Editas MedicineEDIT | $390.9M | $2.55 | -6.43% | United States |
| 463 | BlossomHill TherapeuticsBLSM | $385.2M | $12.12 | -2.10% | United States |
| 464 | AltimmuneALT | $382.2M | $1.97 | -7.31% | United States |
| 465 | Tectonic TherapeuticTECX | $382.0M | $19.54 | -3.74% | United States |
| 466 | SS Innovations InternationalSSII | $380.9M | $1.90 | -16.30% | India |
| 467 | Allogene TherapeuticsALLO | $380.0M | $1.10 | -7.56% | United States |
| 468 | TevogenTVGN | $377.4M | $5.56 | -2.80% | United States |
| 469 | Mobia MedicalMOBI | $376.0M | $11.30 | +0.49% | United States |
| 470 | C4 TherapeuticsCCCC | $362.3M | $2.95 | -5.61% | United States |
| 471 | Zura BioZURA | $362.2M | $3.76 | -6.47% | Cayman Islands |
| 472 | Orthofix MedicalOFIX | $361.7M | $8.88 | -8.64% | United States |
| 473 | Lyell ImmunopharmaLYEL | $360.9M | $14.68 | -4.86% | United States |
| 474 | EmbectaEMBC | $358.7M | $6.33 | -2.91% | United States |
| 475 | TRex BioTRXB | $355.7M | $12.96 | -4.35% | United States |
| 476 | Avalo TherapeuticsAVTX | $355.6M | $6.63 | -6.22% | United States |
| 477 | RezoluteRZLT | $354.5M | $3.67 | -7.45% | United States |
| 478 | Contineum TherapeuticsCTNM | $353.2M | $9.00 | -8.12% | United States |
| 479 | AunaAUNA | $341.9M | $4.62 | -0.22% | Peru |
| 480 | Viemed HealthcareVMD | $341.8M | $9.02 | -10.78% | United States |
| 481 | Orchestra BioMedOBIO | $340.2M | $5.66 | -5.67% | United States |
| 482 | Atea PharmaceuticalsAVIR | $338.9M | $4.23 | -5.27% | United States |
| 483 | IRulya TherapeuticsIRLA | $335.1M | $30.91 | -2.40% | United States |
| 484 | Aspen NeuroscienceASPE | $335.0M | $11.52 | -9.72% | United States |
| 485 | Opus GeneticsIRD | $334.0M | $4.02 | -5.97% | United States |
| 486 | Autolus TherapeuticsAUTL | $332.7M | $1.25 | -9.42% | United Kingdom |
| 487 | AgomAb TherapeuticsAGMB | $332.4M | $6.75 | -1.46% | Belgium |
| 488 | CapsoVisionCV | $332.2M | $6.25 | -8.83% | United States |
| 489 | SndlSNDL | $330.9M | $1.36 | -3.55% | Canada |
| 490 | Fennec PharmaceuticalsFENC | $327.6M | $9.35 | -9.66% | United States |
| 491 | Community Health SystemsCYH | $322.2M | $2.29 | -3.99% | United States |
| 492 | ProkidneyPROK | $322.0M | $1.07 | -4.91% | United States |
| 493 | Aurora CannabisACB | $321.2M | $5.19 | -1.05% | Canada |
| 494 | Eikon TherapeuticsEIKN | $315.8M | $5.83 | -8.76% | United States |
| 495 | X4 PharmaceuticalsXFOR | $314.0M | $3.08 | -5.09% | United States |
| 496 | AlectorALEC | $310.6M | $2.10 | -8.11% | United States |
| 497 | Benitec BiopharmaBNTC | $303.2M | $8.69 | -6.36% | United States |
| 498 | Galectin TherapeuticsGALT | $301.2M | $2.98 | -14.12% | United States |
| 499 | Emergent BioSolutionsEBS | $300.0M | $5.84 | -1.10% | United States |
| 500 | Enanta PharmaceuticalsENTA | $294.2M | $10.10 | -5.16% | United States |
Showing 401–500 of 1,019 companies. One row per company, with secondary share classes folded into their primary listing.
Industries in Health Care
Biotechnology: Pharmaceutical Preparations 498Biotechnology: Biological Products (No Diagnostic Substances) 163Medical Specialities 43Medical/Dental Instruments 124Medicinal Chemicals and Botanical Products 26Industrial Specialties 28Other Pharmaceuticals 10Hospital/Nursing Management 14Biotechnology: Electromedical & Electrotherapeutic Apparatus 26Biotechnology: Commercial Physical & Biological Resarch 12Biotechnology: In Vitro & In Vivo Diagnostic Substances 19Medical Electronics 4Ophthalmic Goods 8Medical/Nursing Services 29Misc Health and Biotechnology Services 10Precision Instruments 3Pharmaceuticals and Biotechnology 1Managed Health Care 1
Other sectors
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.